Last Updated:
2:25 pm
Thursday, June 26, 2025
OncoSil Medical Ltd. develops and commercializes neurology services, including those for pancreatic cancer. It engages in the development of novel and safer radiation therapy treatments. The company was founded by David McAuliffe on April 14, 2005 and is headquartered in North Sydney, Australia.
asx-osl
Market Cap
AU$10.60M
Volume
39381
Open
1.05
AU$
High
1.18
AU$
Low
1.02
AU$
Shares On Issue
10M
52 Week Low
0.8
AU$
52 Week High
6
AU$
Website
www.oncosil.com.au
Consensus
N/A
Last Report Date
N/A
Next Report Date
N/A
Next Dividend date
N/A
Short Sell
N/A
Short Sell Change (1mth)
N/A
Free ASX Market Outlook & Top Stock Picks for 2025
Instantly access our exclusive report and see which stocks our analysts are backing for growth this year.
Download Free Report
Related
Our friendly team is here to help.
If you have any questions or feedback about our service, please feel free to contact us.
© Australian Stock Report Pty Ltd. All rights reserved